The Enterprise Value as of December 2025 (TTM) for BridgeBio Oncology Therapeutics Inc. (BBOT) is 517.22M

According to BridgeBio Oncology Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 517.22M. This represents a change of 294.05% compared to the average of 131.26M of the last 4 quarters.

BridgeBio Oncology Therapeutics Inc. (BBOT) Historical Enterprise Value (quarterly & annually)

How has BBOT Enterprise Value performed in the past?

The mean historical Enterprise Value of BridgeBio Oncology Therapeutics Inc. over the last ten years is 199.84M. The current 517.22M Enterprise Value has changed 25.78% with respect to the historical average. Over the past ten years (40 quarters), BBOT's Enterprise Value was at its highest in in the March 2025 quarter at 264.69M. The Enterprise Value was at its lowest in in the September 2025 quarter at -133619780.00.

BridgeBio Oncology Therapeutics Inc. (BBOT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BridgeBio Oncology Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BridgeBio Oncology Therapeutics Inc. (BBOT) Average Enterprise Value

How has BBOT Enterprise Value performed in the past?

The current Enterprise Value of BridgeBio Oncology Therapeutics Inc. (BBOT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BridgeBio Oncology Therapeutics Inc. (BBOT) Enterprise Value vs. Peers

How is BBOT’s Enterprise Value compared to its peers?

BridgeBio Oncology Therapeutics Inc.’s Enterprise Value is less than Mind Medicine (MindMed) Inc. (919.17M), less than UroGen Pharma Ltd. (1.17B), less than Nurix Therapeutics, Inc. (1.36B), less than Xencor, Inc. (1.46B), less than Kodiak Sciences Inc. (1.30B), less than AnaptysBio, Inc. (1.10B), less than Phathom Pharmaceuticals, Inc. (913.24M), less than Oculis Holding AG (765.09M), less than Tango Therapeutics, Inc. (1.09B), less than Septerna, Inc. (875.41M),

Build a custom stock screener for BridgeBio Oncology Therapeutics Inc. (BBOT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Oncology Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BridgeBio Oncology Therapeutics Inc. (BBOT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BridgeBio Oncology Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.